ERIBULINE ADVANZ PHARMA 0,44 mg/mL, solution injectable

( ARTG ) ERIBULIN DR.REDDYS is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimen for advanced disease.​​​‍​​‍​​​​‍​​‍‍ Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting unless these are contraindicated.,ERIBULIN DR.REDDYS is indicated for the treatment of patients with unresectable liposarcoma who have received prior chemotherapy for advanced or metastatic disease.